Mobocertinib, Asciminib & Surufatinib Among Latest New Filings In EU

 
• By Neena Brizmohun
  
Marketing applications for new drugs are under review in the EU. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography